/ORI.CN
ORI.CN Stock - Orion Nutraceuticals Inc.
Healthcare|Drug Manufacturers - Specialty & GenericCNQ
$0.40+0.00%
+$0.00 (+0.00%) • Jul 23
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.44
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ORI.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.40 – $0.40
TARGET (TP)$0.46
STOP LOSS$0.37
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.14
52W High$0.40
52W Low$0.40
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-316,000 | $-280,000 | $-2,888,000 | $-532,000 | $-700,000 |
| Net Income | $-61,822 | $-280,000 | $-4,958,000 | $-1,233,000 | $-229,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.00 | $-0.01 | $-0.09 | $-0.03 | $-0.20 |
Company Overview
Orion Nutraceuticals Inc. focuses on the drug for treating asthma and chronic obstructive pulmonary diseases in Canada. The company was formerly known as Cline Capital Corp. Orion Nutraceuticals Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ORI.CNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q2 2025
EPS Surprise History
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q1 24
No data
Q2 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Apr 15, 2025 | — | $-0.00 | — | — |
Q1 2025 | Feb 7, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 30, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 31, 2024 | — | $-0.01 | — | — |
Q1 2024 | Feb 29, 2024 | — | $-0.00 | — | — |
Q1 2024 | Feb 8, 2024 | — | $0.01 | — | — |
Q4 2023 | Oct 20, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 31, 2023 | — | $-0.01 | — | — |
Q1 2023 | Feb 28, 2023 | — | $-0.01 | — | — |
Q4 2022 | Nov 30, 2022 | — | $0.00 | — | — |
Q3 2022 | Aug 31, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 31, 2022 | — | $-0.09 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 30, 2021 | — | $0.00 | — | — |
Q3 2021 | Aug 31, 2021 | — | $0.00 | — | — |
Q2 2021 | May 31, 2021 | — | $-0.01 | — | — |
Q1 2021 | Feb 28, 2021 | — | $-0.00 | — | — |
Q4 2020 | Nov 30, 2020 | — | $-0.01 | — | — |
Q3 2020 | Aug 31, 2020 | — | $-0.02 | — | — |
Q2 2020 | May 31, 2020 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ORI.CN
What is ORI.CN's current stock price?
Orion Nutraceuticals Inc. (ORI.CN) is currently trading at $0.40 per share. The stock has moved +0.00% today.
What is the analyst price target for ORI.CN?
No analyst price targets are currently available for this stock.
What sector is Orion Nutraceuticals Inc. in?
Orion Nutraceuticals Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the CNQ exchange.
What is ORI.CN's market cap?
Orion Nutraceuticals Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does ORI.CN pay dividends?
No, Orion Nutraceuticals Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCDX.V
Cloud DX Inc.
$0.13
Mkt Cap: $0.0B
CHAL.CN
Chalice Brands Ltd.
$0.23
Mkt Cap: $0.0B
CNFA.CN
CanaFarma Hemp Products Corp.
$0.05
Mkt Cap: $0.0B
DOC.V
CloudMD Software & Services Inc.
$0.04
Mkt Cap: $0.0B
EXM.CN
EXMceuticals Inc.
$0.20
Mkt Cap: $0.0B
KHRN.V
Khiron Life Sciences Corp.
$0.04
Mkt Cap: $0.0B
NVG.CN
Nass Valley Gateway Ltd.
$0.04
Mkt Cap: $0.0B
RIV.CN
RIV Capital Inc.
$0.10
Mkt Cap: $0.0B
RYAH.CN
RYAH Group, Inc.
$0.03
Mkt Cap: $0.0B
VIVO.TO
VIVO Cannabis Inc.
$0.03
Mkt Cap: $0.0B
Explore stocks similar to ORI.CN for comparison